ArticleOncotarget2017

Human melanoma cells resistant to MAPK inhibitors can be effectively targeted by inhibition of the p90 ribosomal S6 kinase.

Corinna Kosnopfel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.